Men with advanced prostate cancer that has started growing again after androgen-deprivation therapy may benefit from a new immunotherapy treatment.
People who want to look younger have a number of options for nonsurgical treatments for the face, such as injections of dermal fillers or laser treatments.
Hepatitis C is caused by a virus, but it can go undetected for years or even decades because there are often no symptoms. If left untreated, the virus can cause inflammation of liver tissue that can lead to cirrhosis.
Researchers used a driving simulator to explore why talking on a cell phone while driving is more distracting than talking to a passenger in the car.
A survey of hundreds of thousands of Americans found that people in middle and older age were happier overall than younger people.
What is catatonia? You hardly hear about it anymore. Has it been cured?
It is estimated that 1 of 150 children is affected by an autism spectrum disorder. There are no biological tests to identify ASDs, so diagnosis is a challenge.
Daily doses of “friendly” bacteria may help colicky babies cry less, a new study finds. The study included 50 babies, ages 2 to 16 weeks old. All of them were fed only breast milk. On average, they cried about 5 to 6 hours a day. Half of the babies were randomly assigned to receive drops containing Lactobacillus reuteri bacteria. These are known as probiotic bacteria. They may help digestion and also crowd out harmful bacteria in the gut. The other half of the babies received placebo drops. Mothers kept diaries recording how much their babies cried during the 3-week study. By the end, both groups were crying less. But crying time dropped much more in the group that received the probiotic bacteria. Their average crying time was 35 minutes a day, compared with 90 minutes for the placebo group. The journal Pediatrics published the study online.
I have genital herpes and I have recently started thinking about having children. I am concerned about transferring the disease to the child. What are the risks?
Shire PLC has pulled its drug ProAmatine from the U.S. market after regulators threatened to withdraw approval. In a letter posted online August 16, the Food and Drug Administration said Shire had failed to do follow-up research. The FDA approved ProAmatine in 1996 to treat very low blood pressure. It based that decision on early research, but told Shire to do more studies to prove long-term benefits. Shire never submitted them. The FDA letter this week offered to discuss the matter at a hearing. Instead, Shire announced that it would remove the drug by the end of September, the Associated Press (AP) said. The FDA has the power to remove drugs when follow-up studies are not done. However, it has never done so. Shire’s decision does not completely remove the drug from the market. It is also sold as a generic drug, known as midodrine.